These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 33132161)

  • 1. Is it time for microbiome-based therapies in viral infections?
    Sadiq FA
    Virus Res; 2021 Jan; 291():198203. PubMed ID: 33132161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral Infections, the Microbiome, and Probiotics.
    Harper A; Vijayakumar V; Ouwehand AC; Ter Haar J; Obis D; Espadaler J; Binda S; Desiraju S; Day R
    Front Cell Infect Microbiol; 2020; 10():596166. PubMed ID: 33643929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics and Covid-19.
    Bottari B; Castellone V; Neviani E
    Int J Food Sci Nutr; 2021 May; 72(3):293-299. PubMed ID: 32787470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapy.
    Brenchley JM; Serrano-Villar S
    Microbiome; 2024 Jun; 12(1):113. PubMed ID: 38907315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation.
    Elangovan A; Allegretti JR; Fischer M
    Expert Opin Biol Ther; 2019 Dec; 19(12):1343-1355. PubMed ID: 31570017
    [No Abstract]   [Full Text] [Related]  

  • 6. Gut Microbiome (Bacteria, Fungi, and Viruses) and HIV Infection: Revealing Novel Treatment Strategies.
    Ma J; Wen S; Dong A; Fan W; Kang Y
    Mol Nutr Food Res; 2023 Dec; 67(23):e2300566. PubMed ID: 37867202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review on the Alteration of Gut Microbiota: The Role of HIV Infection and Old Age.
    Ashuro AA; Lobie TA; Ye DQ; Leng RX; Li BZ; Pan HF; Fan YG
    AIDS Res Hum Retroviruses; 2020 Jul; 36(7):556-565. PubMed ID: 32323556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study Insights into Gastrointestinal Cancer through the Gut Microbiota.
    Kong F; Cai Y
    Biomed Res Int; 2019; 2019():8721503. PubMed ID: 31341907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers.
    Singh D; Khan MA; Siddique HR
    Life Sci; 2021 Nov; 285():120008. PubMed ID: 34606851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Microbiota-A Promising Target for Antiviral Therapy?
    Yang M; Yang Y; He Q; Zhu P; Liu M; Xu J; Zhao M
    Front Immunol; 2021; 12():676232. PubMed ID: 34054866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Probiotics in Human Gut Microbiome-Associated Diseases.
    Kim SK; Guevarra RB; Kim YT; Kwon J; Kim H; Cho JH; Kim HB; Lee JH
    J Microbiol Biotechnol; 2019 Sep; 29(9):1335-1340. PubMed ID: 31434172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
    Yousef M; Rob M; Varghese S; Rao S; Zamir F; Paul P; Chaari A
    Life Sci; 2024 Apr; 342():122535. PubMed ID: 38408636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases.
    Mahmud MR; Akter S; Tamanna SK; Mazumder L; Esti IZ; Banerjee S; Akter S; Hasan MR; Acharjee M; Hossain MS; Pirttilä AM
    Gut Microbes; 2022; 14(1):2096995. PubMed ID: 35866234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota medicine: towards clinical revolution.
    Gebrayel P; Nicco C; Al Khodor S; Bilinski J; Caselli E; Comelli EM; Egert M; Giaroni C; Karpinski TM; Loniewski I; Mulak A; Reygner J; Samczuk P; Serino M; Sikora M; Terranegra A; Ufnal M; Villeger R; Pichon C; Konturek P; Edeas M
    J Transl Med; 2022 Mar; 20(1):111. PubMed ID: 35255932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of probiotics in gut microbial homeostasis and Rheumatoid arthritis.
    Balasundaram D; Veerasamy V; Sylvia Singarayar M; Neethirajan V; Ananth Devanesan A; Thilagar S
    Int Immunopharmacol; 2024 Aug; 137():112501. PubMed ID: 38885604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates.
    Khan A; Ding Z; Ishaq M; Bacha AS; Khan I; Hanif A; Li W; Guo X
    Int J Biol Sci; 2021; 17(3):818-833. PubMed ID: 33767591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.